Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults

Vaccine

Volumn 26, Issue 27-28, 2008, Pages 3438-3442

  Roukens, A H ^a   Vossen, A C ^a   van Dissel, J T ^a   Visser, L G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Intradermal; Pre exposure; Rabies vaccine

Indexed keywords

PURIFIED CHICK EMBRYO CELL VACCINE; RABIES VACCINE;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHICK EMBRYO; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EMBRYO CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; FEMALE; FEVER; HUMAN; IMMUNOGENICITY; LYMPH NODE SWELLING; LYMPHADENOPATHY; MALE; MYALGIA; PAIN; PRIORITY JOURNAL; PRURITUS; RABIES; RABIES VIRUS; SEROCONVERSION; SWELLING; VACCINATION;

ADULT; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; RABIES; RABIES VACCINES; VACCINATION;

EID: 44749087587     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.04.033     Document Type: Article

References (22)

1. Plotkin S.A., Rupprecht C.E., and Koprowski H. Rabies Vaccine. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 3rd ed. (1999), W.B. Saunders Company, Philadelphia 743-766
2. World Health Organization. Weekly epidemiological record. Rabies Vaccines 82 (2007) 425-436
3. Turner G.S., Nicholson K.G., Tyrell D.A., and Aoki F.Y. Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization. J Hyg (Lond) 89 1 (1982) 101-110
4. Warrell M.J., Warrell D.A., Suntharasamai P., Viravan C., Sinhaseni A., Udomsakdi D., et al. An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis. Lancet 2 8345 (1983) 301-304
5. Madhusudana S.N., Sanjay T.V., Mahendra B.J., Sudarshan M.K., Narayana D.H., Giri A., et al. Comparison of safety and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 mL. Hum Vaccine 2 5 (2006) 200-204
6. Quiambao B.P., Dimaano E.M., Ambas C., Davis R., Banzhoff A., and Malerzcyk C. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Vaccine 23 14 (2005) 1709-1714
7. Nicholson K.G., Farrow P.R., Bijok U., and Barth R. Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical responses in man. Vaccine 5 3 (1987) 208-210
8. Dreesen D.W., Fishbein D.B., Kemp D.T., and Brown J. Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization. Vaccine 7 5 (1989) 397-400
9. Briggs D.J., and Schwenke J.R. Longevity of rabies antibody titer in recipients of human diploid cell rabies vaccine. Vaccine 10 2 (1992) 125-129
10. Malerzcyk C., Briggs D.J., Dreesden D.W., and Banzhoff A. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine. J Travel Med 14 1 (2007) 63-64
11. Aoki F.Y., Tyrrell D.A., and Hill L.E. Immunogenicity and acceptability of a human diploid cell culture rabies vaccine in volunteers. Lancet 1 (1975) 660-662
12. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Human rabies prevention - United States, 1999;48(RR-1):1-21.
13. World Health Organization Department of Communicable Diseases Surveillance and Responses. Current WHO guide for rabies pre- and post-exposure treatment in humans. http://www.who.int/rabies/en/WHO_guide_rabies_pre_post_exp_ treat_humans.pdf (accessed on 24-08-2007).
14. Landelijk Coördinatiecentrum Reizigersadvisering (LCR). Dutch national guidelines for traveler's vaccinations and advices; 2007.
15. Center for Disease Control, Mantoux Tuberculosis Skin Test Facilitator Guide. http://www.cdc.gov/tb/pubs/Mantoux/part1.htm (accessed 3rd of September 2007).
16. Wiktor T., Gyorgy E., Schlumberger H., Sokol F., and Koprowski H. Antigenic properties of rabies virus components. J Immunol 110 1 (1973) 269-276
17. Feyssaguet M., Dacheux L., Audry L., Compoint A., Morize J.L., Blanchard I., et al. Multicenter comparative study of a new ELISA, PLATELIATM RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people. Vaccine 25 12 (2007) 2244-2251
18. Strady A., Lang J., Lienard M., Blondeau C., Jaussaud R., and Plotkin S.A. Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. J Infect Dis 177 5 (1998) 1290-1295
19. Kamoltham T., Thinyounyong W., Phongchamnaphai P., Phraisuwan P., Khawplod P., Banzhoff A., et al. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe. J Pediatr 151 2 (2007) 173-177
20. Belshe R.B., Newman F.K., Cannon J., Duane C., Treanor J., van Hoecke C., et al. Serum antibody response after intradermal vaccination against influenza. N Engl J Med 351 22 (2004) 2286-2294
21. Kenney R.T., Frech S.A., Muenz L.R., Villar C.P., and Glenn G.M. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 351 22 (2004) 2295-2301
22. Roukens A.H., Vossen A.C., Bredenbeek P.J., van Dissel J.T., and Visser L.G. Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: A randomized controlled non-inferiority trial. PLoS ONE 3 4 (2008) e1993